Metabolic Effects Comparable with Roux-en-Y vs Diet in Type 2 Diabetes
In patients with obesity and type 2 diabetes, metabolic improvements were similar after weight loss induced by surgery or a low-calorie diet.
Poll: Give COVID-19 Vaccine to High-risk Americans First
A Harris Poll finds Americans want a US-approved COVID-19 vaccine allocated here first, the rest of the world next, and our most vulnerable take priority.
ID Expert Caught up in COVID-19: Switching Gears
VIDEO: NIH-funded infectious disease expert discusses convalescent plasma, remdesivir, corticosteroids, and the COVID-19 vaccine timeline.
Primary Care Can Lead in CVD Prevention
VIDEO: Preventive cardiology is a multidisciplinary therapeutic area and primary care clinicians have the advantage of greatest patient exposure to help advance care.
Study: Flu Vaccination in Hospitalized High-risk Patients "Paradoxically" Underutilized
Groups at high risk for influenza and its complications were less likely to receive vaccination while hospitalized vs the general population, according to a new study.
VIDEO: Preventive Cardiology in 2020: Room for Improvement
VIDEO: Treatment for ASCVD patients at high risk is lagging behind the availability of powerful new therapies. And, the pandemic does not help, according to Seth Baum, MD.
Risk of Death from COVID-19 Among Obese Higher for Men, Younger Adults
Patients with severe obesity are 4-times as likely to die from COVID-19, a new study finds, with younger patients and men with obesity at highest risk.
COVID-19: CDC Reports Increased Suicidal Thoughts Among Young Adults, Caregivers, Essential Workers
The CDC reports an alarming level of pandemic-related psychological and behavioral distress including thoughts of suicide across US population segments.
COVID-19 and Influenza: How Can We Mitigate Certain Calamity?
A pulmonary and critical care specialist identifies 4 factors that will, in part, determine the severity of the 2020-2021 flu season and that can inform preparation.
Remdesivir New Drug Application Submitted to FDA
The investigational antiviral remdesivir in phase 3 clinical trials led to faster time to recovery vs placebo and was found to be safe.
NIH Names 7 Companies for COVID-19 Testing Scaleup
NIH "shark tank" week yields 7 COVID-19 diagnostic testing companies now awarded $2.5 million to scale up rapid lab and point-of-care testing.
NIH Updates COVID-19 Treatment Guidance on Corticosteroids, Advance Planning
The National Institutes of Health updated guidance on use of dexamethasone and substitutes in critically ill patients, and on ensuring surrogate decision makers are identified.
COVID-19 Update: US and Global Cases, Deaths, and Recoveries as of July 31, 2020
US confirmed cases of COVID-19 number nearly 4.5 million; global cases have surpassed 17 million. We summarize more of today's data from the Johns Hopkins COVID-19 interactive map.
US Vaccination Rates Ranked by State: 5 Highest, 5 Lowest in 8 Categories
Flu vaccination coverage for adults is highest in West Virginia, lowest in Louisiana. Where does your state rank on flu, HPV, pneumococcal and 5 other vaccines?
Heart Attack vs COVID-19 Fear: Half of Hispanics, Blacks Would Avoid Hospital for Cardiac Symptoms
Fear of contracting COVID-19 would keep more than half of Hispanics and Blacks experiencing heart attack/stroke symptoms from going to a hospital.
COVID-19 Update: US and Global Cases, Deaths, and Recoveries as of July 30, 2020
Hypertension Treatment: "Put Simply, it's Complicated"
Patients with hypertension are complex and pose a real challenge to primary care. Brigham and Women's cardiologist Dr Naomi Fisher offers history and highlights.
COVID-19 Update: US and Global Cases and Recoveries as of July 28, 2020
Global confirmed cases of COVID-19 are approaching 16.5 million. We summarize more of today's global and US data from the Johns Hopkins COVID-19 interactive map.
Phase 3 Trial of Moderna/NIH COVID-19 Vaccine Candidate is Launched
COVID-19 vaccine hopeful mRNA-1273 will be administered to 30,000 trial volunteers at 89 US research sites.
FDA Requires Opioid Class Label Change to Promote Naloxone Discussion
All makers of opioid and opioid use disorder medications must revise labels to recommend discussion and coprescribing of naloxone.
COVID-19 Update: US and Global Cases and Recoveries as of July 27, 2020
Global confirmed cases of COVID-19 have surpassed 16 million. We summarize more of today's global and US data from the Johns Hopkins COVID-19 interactive map.
FDA Approves Triple Fixed-dose Inhaled Therapy for COPD
Approval was awarded to AstraZeneca for an inhaled, fixed-dose combination of budesonide/glycopyrrolate/formoterol fumarate.
ASCVD Risk Hit Hard by COVID-19: A Lipidologist's View
Preventive cardiology and lipid specialist Seth J. Baum, MD, answers questions about the state of preventive cardiology in the midst of COVID-19.
Study: After COVID-19, Symptoms Persist for Majority of Patients
JAMA: After recovery from COVID-19, a majority of patients reported persistence of at least 1 symptom; more than half reported ≥3 symptoms.
FDA Approves New Nonopioid Analgesic for Mild/Moderate Musculoskeletal Pain
Galt Pharmaceuticals announced FDA approval of Orphengesic Forte (orphenadrine citrate, aspirin, caffeine), to treat acute mild to moderate pain.
Oxford U/AstraZeneca COVID-19 Vaccine Yields Positive Response in Phase 1/2 Trial
Coronavirus vaccine candidate from Oxford University and AstraZeneca shows robust humoral and cellular response; phase 2/3 trials underway.
FDA Alert: Hand Sanitizer Methanol Contamination
Hand sanitizer products contaminated with methyl alcohol have caused serious adverse events, including hospitalization, blindness, and death.
Medicare Use of Telehealth During COVID-19
Medicare beneficiary use of telehealth services reached nearly 9 million as COVID-19 shut down on-site visits. Will the options be permanent?
Obesity Could Stymie Preventive Cardiology Efforts
VIDEO: Obesity is a chronic, relapsing disease that threatens to neutralize, even reverse, years of progress in reducing CVD-related death. Ted Kyle, RPh, explores.
Survey: More than One-quarter of Parents Hesitant to Vaccinate Children Against Flu
Parental doubts about efficacy drive flu-shot hesitancy, according to a new survey, and impact routine vaccination rates, as well.